Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Construction in Progress (2022 - 2025)

Apyx Medical's Construction in Progress history spans 4 years, with the latest figure at $162000.0 for Q4 2025.

  • For Q4 2025, Construction in Progress fell 74.49% year-over-year to $162000.0; the TTM value through Dec 2025 reached $162000.0, down 74.49%, while the annual FY2025 figure was $162000.0, 74.49% down from the prior year.
  • Construction in Progress reached $162000.0 in Q4 2025 per APYX's latest filing, down from $635000.0 in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $635000.0 in Q4 2024 to a low of $162000.0 in Q4 2025.
  • Average Construction in Progress over 4 years is $463571.4, with a median of $507000.0 recorded in 2022.
  • Peak YoY movement for Construction in Progress: surged 58.75% in 2024, then plummeted 74.49% in 2025.
  • A 4-year view of Construction in Progress shows it stood at $507000.0 in 2022, then dropped by 21.1% to $400000.0 in 2023, then soared by 58.75% to $635000.0 in 2024, then plummeted by 74.49% to $162000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Construction in Progress are $162000.0 (Q4 2025), $635000.0 (Q4 2024), and $400000.0 (Q4 2023).